Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Biaxin® (clarithromycin) – New warning
February 22, 2018 - The FDA announced that a new warning will be added to Biaxin (clarithromycin) drug labels regarding a potential increased risk of heart problems or death that can occur years after use.
